Protocadherin-18 Is a Novel Differentiation Marker and an Inhibitory Signaling Receptor for CD8+ Effector Memory T Cells
Edwin Vazquez‐Cintron(New York University), Alan B. Frey(New York University)
Cited by 18
Related Papers
MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells
|The Journal of Experimental Medicine|2012|298
Dendritic Cell Populations With Different Concentrations of Lipid Regulate Tolerance and Immunity in Mouse and Human Liver
|Gastroenterology|2012|172
Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug Delivery
|Scientific Reports|2017|26